New Drugs

Brand/Generic Company Description
Ayvakit
avapritinib
Click here for more information
Blueprint Medicines

A kinase inhibitor for advanced gastrointestinal stromal tumor (GIST).

Bafiertam
monomethyl fumarate
Click here for more information
Banner Life Sciences

The active metabolite of dimethyl fumarate for multiple sclerosis.

Barhemsys
amisulpride
Click here for more information
Acacia Pharma

A dopamine-2 antagonist for prevention and treatment of postop nausea and vomiting.

Darzalex Faspro
daratumumab/ hyaluronidase-fihj
Click here for more information
Janssen Biotech

Combination monoclonal antibody and hyaluronidase for multiple myeloma.

Isturisa
osilodrostat
Click here for more information
Recordati Rare Diseases

A cortisol synthesis inhibitor for Cushing’s disease.

Koselugo
selumetinib
Click here for more information
AstraZeneca

A kinase inhibitor for pediatric neurofibromatosis type 1.

Nexletol
bempedoic acid
Click here for more information
Esperion

An adenosine triphosphate-citrate lyase inhibitor for hypercholesterolemia.

Nexlizet
bempedoic acid/ezetimibe
Click here for more information
Esperion

An adenosine triphosphate-citrate lyase inhibitor and cholesterol absorption inhibitor for hypercholesterolemia.

Nurtec ODT
rimegepant
Click here for more information
Biohaven Pharm.

A calcitonin gene-related peptide receptor antagonist for acute treatment of migraine.

Ongentys
opicapone
Click here for more information
Neurocrine Biosciences

A COMT inhibitor for Parkinson’s disease patients experiencing “off” episodes.

Palforzia
peanut (Arachis hypogaea) allergen powder-dnfp
Aimmune Therapeutics

An oral immunotherapy for patients with peanut allergy.

Pemazyre
pemigatinib
Click here for more information
Incyte Corp.

A kinase inhibitor for advanced cholangiocarcinoma.

Pizensy
lactitol
Click here for more information
Braintree Labs

An osmotic laxative for chronic idiopathic constipation.

Qinlock
ripretinib
Click here for more information
Deciphera Pharm.

A kinase inhibitor for advanced gastrointestinal stromal tumor (GIST).

Retevmo
selpercatinib
Click here for more information
Lilly

A kinase inhibitor for metastatic non-small cell lung cancer and medullary thyroid cancer.

Sarclisa
isatuximab-irfc
Click here for more information
Sanofi-Aventis U.S.

A monoclonal antibody for multiple myeloma.

Sevenfact
factor VIIa (recombinant)-jncw
Click here for more information
HEMA Biologics

A coagulation factor to control bleeding episodes in patients with hemophilia A or B with inhibitors (neutralizing antibodies).

Tabrecta
capmatinib
Click here for more information
Novartis Pharm.

A kinase inhibitor for metastatic non-small cell lung cancer.

Tazverik
tazemetostat
Click here for more information
Epizyme

A methyltransferase inhibitor for advanced epithelioid sarcoma.

Tepezza
teprotumumab-trbw
Click here for more information
Horizon

A monoclonal antibody for thyroid eye disease.

Trodelvy
sacituzumab govitecan-hziy
Click here for more information
Immunomedics

A monoclonal antibody for metastatic breast cancer.

Tukysa
tucatinib
Click here for more information
Seattle Genetics

A kinase inhibitor for advanced breast cancer.

Vyepti
eptinezumab-jjmr
Click here for more information
Lundbeck

A calcitonin gene-related peptide antagonist for prevention of migraine.

Zeposia
ozanimod
Click here for more information
Celgene

An oral sphingosine 1-phosphate receptor modulator for relapsing forms of multiple sclerosis.

Brand/Generic Company Description
Anjeso
meloxicam
Click here for more information
Baudax Bio

An injectable NSAID for moderate to severe pain.

Bynfezia Pen
octreotide
Click here for more information
Sun Pharm.

New subcutaneous pen formulation for patients with acromegaly, carcinoid tumors, or vasoactive intestinal peptide tumors.

Durysta
bimatoprost implant
Click here for more information
Allergan

An implant formulation for reduction of intraocular pressure in patients with open angle glaucoma or ocular hypertension.

Elyxyb
celecoxib
Click here for more information
Promius Pharma

New oral solution formulation for treatment of acute migraine.

Fensolvi
leuprolide
Click here for more information
Tolmar Pharm.

New injectable formulation for pediatric patients with central precocious puberty.

Jelmyto
mitomycin
Click here for more information
UroGen Pharma

New formulation for pyelocalyceal use for upper tract urothelial cancer.

Milprosa
progesterone
Click here for more information
Ferring Pharm.

A progesterone-containing vaginal insert to support embryo implantation and early pregnancy.

Monoferric
ferric derisomaltose
Click here for more information
Pharmacosmos

An intravenous iron replacement formulation for iron deficiency anemia.

Procysbi
cysteamine bitartrate
Click here for more information
Horizon Therapeutics

New delayed-release capsules and oral granules for nephropathic cystinosis.

Trijardy XR
empagliflozin/linagliptin/metformin
Click here for more information
Boehringer Ingelheim

New combination formulation for glycemic control in patients with type 2 diabetes.

Twirla
levonorgestrel/ethinyl estradiol
Click here for more information
Agile Therapeutics

New estrogen/progestin contraceptive patch.

Valtoco
diazepam nasal spray
Click here for more information
Neurelis

New nasal spray formulation for acute treatment of seizure clusters and acute repetitive seizures.

Brand/Generic Company Description
Belviq, Belviq XR
lorcaserin
Click here for more information
Eisai

Voluntary withdrawal from the market due to concerns about an increased occurrence of cancer seen in a clinical trial.

Zantac (and generics)
ranitidine
Click here for more information
Multiple

Withdrawal of all products (prescription and OTC) from the market due to safety concerns of the contaminant NDMA found in ranitidine products.